期刊文献+

乙酰胆碱酯酶与新型香豆素类二聚体抑制剂的作用研究

Theoretical Studies on the Interactions of Acetylcholinesterase and Newly Coumarin Dimmers Inhibitors
下载PDF
导出
摘要 本文通过分子对接的方法研究了香豆素类二聚体作为AChE抑制剂在正常活性位点(Ser203、Glu334和His447)和外周阴离子活性位点(His287、Tyr72、Tyr441和Glu292)的作用情况.研究结果表明,此类抑制剂有两个负电性中心:抑制剂母体的内酯区和6位或7位的苄基区.由于这两部分负电作用比较强极易与周围蛋白质发生静电作用,从而导致氢键的形成.研究发现香豆素二聚体类抑制剂更容易结合在AChE的外周阴离子活性区域.这类抑制剂在外周阴离子活性位点有相同的作用模式.这使得香豆素类二聚体有可能成为一种有更好应用前景的乙酰胆碱酯酶抑制剂. Alzheimerg disease (AD) is a common age - related cognitive dysfunction in neurodegenerative diseases. So far, the drug that used to treat the diseases of AD is based on the acetylcholinesterase (ACHE) inhibitors. In this study, we study the interactions of the AChE with newly coumarin dimmer inhibitors in the regular active site (formed by residues Ser203, Glu334 and His447 ) ) as well as the outer peripheral anionic region ( surrounded by His287, Tyr72, Tyr441 and Glu292) using docking method. Two negative centers have been found on the lactone group or 6 - or 7 - positions of the benzyl group of these inhibi- tots. Studies show that the coumarin dimmer inhibitors are preferred to bind in the outer peripheral anionic region, all of which have similar binding modes. This makes coumarin dimmer inhibitors become a kind of promising AChE inhibitors.
出处 《枣庄学院学报》 2014年第2期59-65,共7页 Journal of Zaozhuang University
基金 山东省优秀中青年科学家科研奖励基金(项目编号:BS2013SW037)
关键词 乙酰胆碱酯酶 抑制剂 香豆素类二聚体抑制剂 Acetyleholinesterase (ACHE) inhibitor coumarin dimmer inhibitors
  • 引文网络
  • 相关文献

参考文献15

  • 1段金海,汪华侨,陈少琼,徐杰,林贤,康庄,姚志彬.阿尔茨海默病患者脑白质损害与认知功能的关系[J].中华神经科杂志,2006,39(2):76-79. 被引量:8
  • 2Bartus R T, Dean R L, Beer B, Lippa A S. A Review of the Behavioral Effects of AF64A, A Cholinergic Neurotoxin. [ J ] Science, 1982,217 : 408 - 417.
  • 3Whitehouse, P. J. [J] Acta Neurol. Scand. Suppl. 1993, 149: 42-45.
  • 4Kelly, C. A. Harvey, R. J. Cayton, H. [J] BMJ 1997, 314:693 -694.
  • 5Scott, L. J. Goa, K. L. [J] Drugs 2000, 60, 1095- 1122.
  • 6Gottwald, M. D. Rozanski, R. I. [J]. Expert Opin. Investig. Drugs 1999, 8, 1673 -1682.
  • 7Thies W, Bleiler L. Alzheimers Association. Alzheimers Association report: 2012 Alzheimers disease facts and figures. [J] Alzheimers Dement, 2012, 8:131-168.
  • 8Marco C, Leonardo P, Francesco L, Orazio N, Paolo P, Angela S,Saverio C, Angelo C. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase [ J]. Bio Med Chem, 2013, 21:146 - 152.
  • 9Yue qing H, Jun Z, Oormila C, Fanny C F, Nancy Y. Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors. [ J] Bio Med Chem, 2012, 20:5678 -5698.
  • 10Gaussian 03 , Revision A. 3. Frisch, M. J. Trucks, G. W. Schlegel, H. B. Scuseria, G. E. Robb, M. A. Cheeseman, J. R. Montgomery, J. A. Vreven, Jr. , T. Kudin, K. N. Burant, J. C. Millam, J. M. Iyengar, S. S. Tomasi, J. Barone, V. Mennucci, B. Cossi, M. Scalmani, G. Rega, N. Petersson, G. A. Nakatsu- ji, H. Hada, M. Ehara, M. Toyota, K. Fukuda, R. Hasegawa, J. Ishida, M. Nakajima, T. Honda, Y. Kitao, O. Nakai, H. Klene, M. Li, X. Knox, J. E. Hratchian, H. P. Cross, J. B. Adamo, C. Jaramillo, J. Gomperts, R. Stratmann, R. E. Yazyev, O. Austin, A. J. Cammi, R. Pomelli, C. Ochterski, J. W. Ayala, P. Y. Morokuma, K. Voth, G. A. Salvador, P. Dannenberg, J. J. Zakrzewski, V. G. Dapprich, S. Daniels, A. D. Strain, M. C. Farkas, O. Malick, D. K. Rabuck, A. D. Raghavachari, K. Foresman, J. B. Ortiz, J. V. Cui, Q. Baboul, A. G. Clifford, S. Cioslowski, J. Stefanov, B. B. Liu, G. Liashenko, A. Piskorz, P. Komaromi, I. Martin, R. L. Fox, D. J. Keith, T. A1- Laham, M. A. Peng, C. Y. Nanayakka- ra, A. Challacombe, M. Gill, P. M. W. Johnson, B. Chen, W. Wong, M. W. Gonzalez, C. and Pople, J. A. Gaussian, Inc. , Pittsburgh PA, 2003.

二级参考文献13

  • 1汤慈美,刘颖.帕金森病患者的智力和视空间知觉障碍[J].中华老年医学杂志,1993,12(4):200-204. 被引量:13
  • 2Bronge L,Bogdanovic N,Wahlund LO.Postmortem MRI and histopathology of white matter changes in Alzheimer brains:A quantitative,comparative study.Dement Geriatr Cogn Disord,2002,13:205-212.
  • 3Han X,Holtzman M,McKeel DW,et al.Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease:potential role in disease pathogenesis.J Neurochem,2002,82:809-818.
  • 4Bozzali M,Falini A,Franceschi M,et al.White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.J Neurol Neurosurg Psychiatry,2002,72:742-746.
  • 5Rose SE,Chen F,Chalk JB,et al.Loss of connectivity in Alzheimer's disease:an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging.J Neurol Neurosurg Psychiatry,2000,69:528-530.
  • 6Choi SJ,Lim KO,Monteiro I,et al.Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease:a preliminary study.J Geriatr Psychiatry Neurol,2005,18:12-19.
  • 7Pearson RC,Esiri MM,Hiorns RW,et al.Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.Proc Natl Acad Sci USA,1985,82:4531-4534.
  • 8Rogers J,Morrison JH.Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.J Neurosci,1985,5:2801-2808.
  • 9Song SK,Kim JH,Lin SJ,et al.Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition.Neurobiol Dis,2004,15:640-647.
  • 10Sun SW,Song SK,Harms MP,et al.Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging.Exp Neurol,2005,191:77-85.

共引文献7

;
使用帮助 返回顶部